These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 27829983)

  • 1. Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms.
    Mack JM; Schamne MG; Sampaio TB; Pértile RA; Fernandes PA; Markus RP; Prediger RD
    Oxid Med Cell Longev; 2016; 2016():3472032. PubMed ID: 27829983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
    Tapias V; Cannon JR; Greenamyre JT
    J Neurosci Res; 2010 Feb; 88(2):420-7. PubMed ID: 19681169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
    Dabbeni-Sala F; Di Santo S ; Franceschini D; Skaper SD; Giusti P
    FASEB J; 2001 Jan; 15(1):164-170. PubMed ID: 11149904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?
    Singhal NK; Srivastava G; Agrawal S; Jain SK; Singh MP
    Mol Neurobiol; 2012 Feb; 45(1):186-99. PubMed ID: 22198804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin/polydopamine nanostructures for collective neuroprotection-based Parkinson's disease therapy.
    Srivastava AK; Roy Choudhury S; Karmakar S
    Biomater Sci; 2020 Mar; 8(5):1345-1363. PubMed ID: 31912833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin and Parkinson's disease.
    Mayo JC; Sainz RM; Tan DX; Antolín I; Rodríguez C; Reiter RJ
    Endocrine; 2005 Jul; 27(2):169-78. PubMed ID: 16217130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
    J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation.
    Su LY; Li H; Lv L; Feng YM; Li GD; Luo R; Zhou HJ; Lei XG; Ma L; Li JL; Xu L; Hu XT; Yao YG
    Autophagy; 2015; 11(10):1745-59. PubMed ID: 26292069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin prevents dopaminergic cell loss induced by lentiviral vectors expressing A30P mutant alpha-synuclein.
    Brito-Armas JM; Baekelandt V; Castro-Hernández JR; González-Hernández T; Rodríguez M; Castro R
    Histol Histopathol; 2013 Aug; 28(8):999-1006. PubMed ID: 23444197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease.
    Willis GL; Armstrong SM
    Physiol Behav; 1999 Jul; 66(5):785-95. PubMed ID: 10405106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
    Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
    J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin Improves Behavioral and Biochemical Outcomes in a Rotenone-Induced Rat Model of Parkinson's Disease.
    Rasheed MZ; Andrabi SS; Salman M; Tabassum H; Shaquiquzzaman M; Parveen S; Parvez S
    J Environ Pathol Toxicol Oncol; 2018; 37(2):139-150. PubMed ID: 30055549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
    Harrison IF; Dexter DT
    Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotenone-Induced Model of Parkinson's Disease: Beyond Mitochondrial Complex I Inhibition.
    Ibarra-Gutiérrez MT; Serrano-García N; Orozco-Ibarra M
    Mol Neurobiol; 2023 Apr; 60(4):1929-1948. PubMed ID: 36593435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23.
    Willis GL; Robertson AD
    Pharmacol Biochem Behav; 2005 Jan; 80(1):9-26. PubMed ID: 15652376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the pathogenetic mechanisms underlying Parkinson's disease in medaka fish.
    Matsui H; Uemura N; Yamakado H; Takeda S; Takahashi R
    J Parkinsons Dis; 2014; 4(2):301-10. PubMed ID: 24366926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New agents promote neuroprotection in Parkinson's disease models.
    Santos CM
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):410-8. PubMed ID: 22483311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model.
    Ozsoy O; Yildirim FB; Ogut E; Kaya Y; Tanriover G; Parlak H; Agar A; Aslan M
    Free Radic Res; 2015; 49(8):1004-14. PubMed ID: 25791066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.